Movement Alert|NEBIUS Falls 3.23% in Regular Trading, $5.75 Billion Convertible Notes Dilution Concerns Continue to Weigh on Stock

Market Focus
Yesterday

On August 31, NEBIUS fell 3.23% in regular trading, trading at $202.59/share, with turnover of $489 million. The stock continues to face selling pressure driven by lingering equity dilution concerns tied to its massive convertible debt issuance.

On August 25, the company completed a $5.75 billion private offering of convertible senior notes in two series: $3.45 billion in 0.50% notes due 2030 with a conversion premium of approximately 40%, and $2.3 billion in 4.50% notes due 2034 with a conversion premium of approximately 45%. Initial buyers exercised their overallotment options in full. Additionally, director Charles E Ryan sold approximately 49,000 shares on August 14 at prices between $263.14 and $269.74, further dampening sentiment.

Although NVIDIA's CFO confirmed on August 27 that Groq 3 LPX would begin volume shipments to Nebius as its first customer this quarter, sparking a brief rally of over 5%, the rebound has since faded. Options market activity has also reflected cautious positioning, with significant bearish put structures observed in recent sessions. Since the convertible note announcement, the stock has retreated substantially from its highs.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10